EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
    3.5.1.6 | beta-ureidopropionase deficiency |
11746386 |
3-Ureidopropionate contributes to the neuropathology of 3-ureidopropionase deficiency and severe propionic aciduria: a hypothesis. |
causal interaction
unassigned |
3
0 |
| 3.5.1.6 | Propionic Acidemia |
11746386 |
3-Ureidopropionate contributes to the neuropathology of 3-ureidopropionase deficiency and severe propionic aciduria: a hypothesis. |
causal interaction
unassigned |
3
0 |
| 3.5.1.6 | beta-ureidopropionase deficiency |
17964839 |
Beta-ureidopropionase deficiency presenting with congenital anomalies of the urogenital and colorectal systems. |
causal interaction
diagnostic usage
unassigned |
4
3
0 |
| 3.5.1.6 | beta-ureidopropionase deficiency |
16417553 |
beta-Ureidopropionase Deficiency Presenting with Febrile Status Epilepticus. |
causal interaction
unassigned |
4
0 |
| 3.5.1.6 | Status Epilepticus |
16417553 |
beta-Ureidopropionase Deficiency Presenting with Febrile Status Epilepticus. |
causal interaction
unassigned |
4
0 |
| 3.5.1.6 | beta-ureidopropionase deficiency |
11675655 |
beta-Ureidopropionase deficiency: a novel inborn error of metabolism discovered using NMR spectroscopy on urine. |
unassigned |
0 |
| 3.5.1.6 | beta-ureidopropionase deficiency |
15385443 |
beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities. |
causal interaction
diagnostic usage
unassigned |
4
3
0 |
| 3.5.1.6 | beta-ureidopropionase deficiency |
16541364 |
Clinical Findings and a Therapeutic Trial in the First Patient with beta-Ureidopropionase Deficiency. |
causal interaction
therapeutic application
unassigned |
4
4
0 |
| 3.5.1.6 | beta-ureidopropionase deficiency |
11783492 |
Confirmation of the enzyme defect in the first case of beta-ureidopropionase deficiency. Beta-alanine deficiency. |
causal interaction
unassigned |
4
0 |
| 3.5.1.6 | Hyperthyroidism |
19684093 |
CTF1/NF1 binding site is important in beta myosin heavy chain antisense promoter regulation. |
ongoing research
unassigned |
2
0 |
